Valeant Pharmaceuticals International Stock Fundamentals
Valeant Pharmaceuticals International fundamentals help investors to digest information that contributes to Valeant Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Valeant Stock. The fundamental analysis module provides a way to measure Valeant Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valeant Pharmaceuticals stock.
Valeant |
Valeant Pharmaceuticals International Company Return On Equity Analysis
Valeant Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Valeant Pharmaceuticals Return On Equity | -21.51 |
Most of Valeant Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valeant Pharmaceuticals International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Valeant Pharmaceuticals International has a Return On Equity of -21.51. This is 10.26% lower than that of the sector and notably lower than that of the Return On Equity industry. The return on equity for all United States stocks is notably higher than that of the company.
Valeant Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valeant Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Valeant Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valeant Pharmaceuticals competition to find correlations between indicators driving Valeant Pharmaceuticals's intrinsic value. More Info.Valeant Pharmaceuticals International is rated below average in return on equity category among related companies. It is rated first in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Valeant Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Valeant Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valeant Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Valeant Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valeant Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Valeant Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Valeant Pharmaceuticals by comparing valuation metrics of similar companies.Valeant Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Valeant Fundamentals
| Return On Equity | -21.51 | |||
| Return On Asset | 0.69 | |||
| Profit Margin | (10.65) % | |||
| Operating Margin | 5.01 % | |||
| Current Valuation | 32.38 B | |||
| Shares Outstanding | 349.3 M | |||
| Shares Owned By Insiders | 0.30 % | |||
| Shares Owned By Institutions | 51.10 % | |||
| Number Of Shares Shorted | 14.62 M | |||
| Price To Earning | 3.43 X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 0.95 X | |||
| Revenue | 8.61 B | |||
| Gross Profit | 6.18 B | |||
| EBITDA | 3.4 B | |||
| Net Income | (917 M) | |||
| Cash And Equivalents | 909 M | |||
| Cash Per Share | 2.60 X | |||
| Total Debt | 25.27 B | |||
| Debt To Equity | 558.60 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 16.77 X | |||
| Cash Flow From Operations | 1.77 B | |||
| Short Ratio | 1.80 X | |||
| Earnings Per Share | 6.83 X | |||
| Price To Earnings To Growth | 3.05 X | |||
| Number Of Employees | 20.7 K | |||
| Beta | -0.93 | |||
| Market Capitalization | 8.17 B | |||
| Total Asset | 2.24 B | |||
| Retained Earnings | (2.75 B) | |||
| Working Capital | (23.53 M) | |||
| Current Asset | 321.63 M | |||
| Current Liabilities | 345.16 M | |||
| Z Score | 4.9 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Valeant Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Valeant Pharmaceuticals' short interest history, or implied volatility extrapolated from Valeant Pharmaceuticals options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Valeant Stock
If you are still planning to invest in Valeant Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Valeant Pharmaceuticals' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |